AN2 Therapeutics enters $80M ATM offering with Jefferies; prior ATM terminated

AN2 Therapeutics, Inc.

Entered into Open Market Sale Agreement with Jefferies to sell up to $80M of common stock at market prices.
Jefferies receives up to 3.0% commission; offering may be terminated by either party on 10 days' notice.
Terminated prior TD Cowen ATM under which 2,502,000 shares were sold for aggregate $20,016,251.
Effective April 9, 2026; no shares have been sold yet under new agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.